“Full Metal Jacket” Drug‐Eluting Stent Implantation

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1051-1052

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improving Outcomes in High-Risk Percutaneous Coronary Interventions and Newer-Generation Drug-Eluting Stents: Good, But Not Good Enough

By  

Cardiology, Vol. 138, Iss. 2, 2017-06 ,pp. : 73-75

Karger

Access to resources Recommend Favorite

Clinical outcome of patients with implantation of second‐generation drug‐eluting stents in the right coronary ostium: Insights from 2‐year follow‐up of the TWENTE trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 524-531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

By Karjalainen Pasi   Ylitalo Antti   Niemela Matti   Kervinen Kari   Makikallio Timo   Pietila Mikko   Sia Jussi   Tuomainen Petri   Nyman Kai   Airaksinen K. E. Juhani  

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 599-607

Informa Healthcare

Access to resources Recommend Favorite

The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta‐Analysis of Bare Metal Stent and Drug‐Eluting Stent Trials

By  

CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol. 33, Iss. 6, 2015-12 ,pp. : 360-366

John Wiley & Sons Inc

Access to resources Recommend Favorite